• vcard
  • Education
    • Ph.D., Cardiff University, United Kingdom, 2015, Medicinal Chemistry
    • B.S., Technical University of Munich, 2009, Physical and Organic Chemistry
  • Bar Jurisdictions
    • Admitted to practice before the United States Patent and Trademark Office

Dr. Jan-Philip Meyer is a registered patent agent and a member of Polsinelli’s Biotechnology and Life Sciences Patent Prosecution practice in Seattle. He focuses his practice on patent prosecution, due diligence for financing rounds and initial public offerings (IPOs), and inter partes review (IPR) proceedings in the chemical, pharmaceutical and life sciences industries. Jan-Philip has represented clients from various biotechnology and life science areas including small molecule, peptide, and protein-based therapeutics and diagnostics, genomics, as well as cell- and gene therapies. 

Jan-Philip’s experience includes conducting translational research at Memorial Sloan Kettering Cancer Center in New York where he designed and evaluated companion diagnostics for small molecule as well as antibody-derived therapeutics. Jan-Philip’s research experience also encompasses protein chemistry using site-specific modification approaches for the development of high-affinity radiotheranostics as well as antibody-drug conjugates. During his doctoral studies at Cardiff University in the United Kingdom, Jan-Philip developed novel radiotracers for the non-invasive imaging of disease, particularly cancer.

  • Prosecuted foundational patent applications for biopharmaceutical company with $177M IPO.
  • Prosecuted foundational patent applications for microbiome company with $30M Series B.
  • Prosecuted foundational patent applications for genomics company with $390M IPO.
text icon Publications & Presentations
Exploring Structural Parameters for Pretargeting Radioligand Optimization
Co-Author, The Journal of Medicinal Chemistry
text icon Publications & Presentations
Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants
Co-Author, 57(11) The Journal of Nuclear Medicine 1811-6, 2016 (Alawi-Mandell Award 2017)
text icon Publications & Presentations
18F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry
Co-Author, 27(2) Bioconjugate Chemistry 298-301